TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
NMPA 2018L02262/2018L02263
Phase 2 small_molecule active
Quick answer
TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone for Prostatic Neoplasms, Castration-Resistant is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Prostatic Neoplasms, Castration-Resistant
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active